Accelerating Data Solutions to Save LIVES from COVID-19

The consortium of COVID-X announces the launch of the ​1st Open Call ​framed in a ​2-year initiative that will invest ​4 million € to fast-track to market 30+ European data technology solutions defeating COVID-19 Challenges, facilitating an innovative stack of AI-driven tools.

COVID-19 pandemic is hitting with force. Europe has passed the threshold of ​250,000 deaths since February 2020.​ COVID-X takes the battle against corona virus to a new level by bridging the gap between the European digital sector and the healthcare system. The program will unlock the full capacity of Artificial Intelligence and Data to fight COVID-19​, validating, and scaling up breakthroughs to save lives.

COVID-X will fund EU Companies and Healthcare Providers to boost data-driven solutions with the power to overcome challenges in Diagnosis, Prognosis, and Follow-up. The funding is invested in products with TRL7+ and [or in the process of] CE marking, covering two profiles: single players (EU Tech SMEs / Start-Ups) validating their solutions at one of COVID-X clinical partners; or ​multiplayers (Tech Provider working with a Healthcare provider that will validate the solution). The selected projects will join an Acceleration Program to boost their quick market uptake. ​This will include technical support, ethical validation, and business coaching.

In addition, participants will have access to the ​COVID-X Sandbox​, a one-stop platform to exploit COVID-19 data sources, incorporating general information on data silos, as well as the integration, visualization, and exploratory analysis for easy understanding. The 1st Open Call Application is now open and the deadline will be on​ the 27th January 2021.

For further information, please visit:
https://www.covid-x.eu

Most Popular Now

Accelerating Data Solutions to Save LIVE…

The consortium of COVID-X announces the launch of the ​1st Open Call ​framed in a ​2-year initiative that will invest ​4 million € to fast-track to market 30+ European data...

Significant Disparities in Telemedicine …

After "COVID-19," the term that most people will remember best from 2020 is likely to be "social distancing." While it most commonly applied to social gatherings with family and friends...

Model Used to Evaluate Lockdowns was Fla…

In a recent study, researchers from Imperial College London developed a model to assess the effect of different measures used to curb the spread of the coronavirus. However, the model...

New Virtual Screening Strategy Identifie…

A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat COVID-19. Haiping Zhang...

Using Artificial Intelligence to Find Ne…

Scientists have developed a machine-learning method that crunches massive amounts of data to help determine which existing medications could improve outcomes in diseases for which they are not prescribed. The intent...

FDA Releases Artificial Intelligence / M…

Today, the U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach...

One in Four Doctors Attacked, Harassed o…

While many physicians benefit from social media by networking with potential collaborators or interfacing with patients, a new study from Northwestern University and the University of Chicago found many physicians...

CliniSys Launches Laboratory Information…

CliniSys has launched a new laboratory information management system for genomic laboratories in the UK. The company has brought GLIMS Genomics to the UK from Europe, where it is being...

The Institute of Healthcare Management C…

The Institute of Healthcare Management has called for honest and open communication about NHS capacity after a snapshot survey revealed the scale of sickness absence across the service. The UK's leading...

First NHS Trust and Sectra Achieve Rapid…

A new region-wide approach to analysing x-rays, MRI scans, CT scans, mammography, and an entire range of crucial diagnostic images, has started to become reality, now that The Pennine Acute...

Bayer Transforms Pharma Business through…

At its virtual Pharma Media Day, Bayer presented exciting progress in transforming its pharmaceutical business with breakthrough innovation in healthcare that will significantly help patients suffering from conditions that are...